A carregar...
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.
Prophylactic treatment with fluoroquinolones of patients with profound neutropenia has been found to be useful for preventing gram-negative bacteremia and has become a standard preventive-therapy strategy in many cancer centers, but the development of bacterial resistance is a cause of concern. Duri...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1994
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284525/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8031031/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.4.681 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|